# Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

> **NCT06812559** · — · COMPLETED · sponsor: **El Shatby University Hospital for Obstetrics and Gynecology** · enrollment: 100 (actual)

## Conditions studied

- Controlled Ovarian Hyperstimulation
- Polycystic Ovarian Syndrome

## Interventions

- **DRUG:** Progesterone
- **DRUG:** GnRH antagonist (Cetrorelix)

## Key facts

- **NCT ID:** NCT06812559
- **Lead sponsor:** El Shatby University Hospital for Obstetrics and Gynecology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06812559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06812559, "Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06812559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*